Top section
Top section
Upper mid-market firms eschew ‘exciting’ stories as cracks emerge in European private credit
Pharmaceuticals and energy transition also ripe sectors for M&A
Borrowers moving between the two markets create opportunities for both
More articles
More articles
More articles
-
Bankers give Galderma and Douglas a decent chance of relying on organic demand -
Despite a few tighter prints last week, pricing is unlikely to compress much further
-
Term loans are back on the agenda in a “borrower-friendly market”
-
While we may not see the immediate benefits of new private credit fund regulation now, we might see them eventually. We hope not to see them at all
-
Investec has grown its private equity advisory offering in ‘transformational moment’ for PE
-
Leveraged companies moving away from LBO capital structures are choosing loans for competitive pricing and flexibility
Sub-sections
shared comment list
